Efficacy and Safety of Nivolumab-Ipilimumab regiments versus Nivolumab Monotherapy and the Predictive Value of PD-L1 Expression Across Advanced Solid Tumors A Systematic Review and Meta Analysis (SITC 2026) - Oct 2, 2026 - Abstract #391; Pres time: Nov 6, 2026; 10:00 AM - 07:00 PM; Location: PCC - Lower Level - North Exhibition Halls 4-5-6; No abstract available
IO biomarker • Metastases • Monotherapy • Retrospective data • Review • Oncology • Solid Tumor
|
|
Lyna Delhoum; M.Yahya El Arabawy; Ahlem Nour El Yakine Bounechada; Ahmed Mohamed S. Gado; Sara Adel Awwad; Mona I. Elshamy; Elsayed S. Moubarak; Zineddine Bellabaci; Monzer Elhussein; Israa Ahmed Qutob
|